221 related articles for article (PubMed ID: 36203870)
1. Comprehensive Characterization of CK1δ-Mediated Tau Phosphorylation in Alzheimer's Disease.
Roth A; Sander A; Oswald MS; Gärtner F; Knippschild U; Bischof J
Front Mol Biosci; 2022; 9():872171. PubMed ID: 36203870
[TBL] [Abstract][Full Text] [Related]
2. Casein Kinase 1δ Phosphorylates TDP-43 and Suppresses Its Function in Tau mRNA Processing.
Yang M; Qi R; Liu Y; Shen X; Zhao Y; Jin N; Wu R; Liu F; Gu J
J Alzheimers Dis; 2023; 91(4):1527-1539. PubMed ID: 36641675
[TBL] [Abstract][Full Text] [Related]
3. Kinase activity of casein kinase 1 delta (CK1δ) is modulated by protein kinase C α (PKCα) by site-specific phosphorylation within the kinase domain of CK1δ.
Meng Z; Böhm T; Xu P; Henne-Bruns D; Peifer C; Witt L; Knippschild U; Bischof J
Biochim Biophys Acta Proteins Proteom; 2019; 1867(7-8):710-721. PubMed ID: 31096047
[TBL] [Abstract][Full Text] [Related]
4. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
5. CK1δ-Derived Peptides as Novel Tools Inhibiting the Interactions between CK1δ and APP695 to Modulate the Pathogenic Metabolism of APP.
Roth A; Gärtner F; Mayer K; Beyrle J; König I; Knippschild U; Bischof J
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203978
[TBL] [Abstract][Full Text] [Related]
6. Tau Phosphorylation Rates Measured by Mass Spectrometry Differ in the Intracellular Brain vs. Extracellular Cerebrospinal Fluid Compartments and Are Differentially Affected by Alzheimer's Disease.
Barthélemy NR; Mallipeddi N; Moiseyev P; Sato C; Bateman RJ
Front Aging Neurosci; 2019; 11():121. PubMed ID: 31178717
[TBL] [Abstract][Full Text] [Related]
7. Pathological Tau From Alzheimer's Brain Induces Site-Specific Hyperphosphorylation and SDS- and Reducing Agent-Resistant Aggregation of Tau
Miao J; Shi R; Li L; Chen F; Zhou Y; Tung YC; Hu W; Gong CX; Iqbal K; Liu F
Front Aging Neurosci; 2019; 11():34. PubMed ID: 30890929
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated tau interactome in the human Alzheimer's disease brain.
Drummond E; Pires G; MacMurray C; Askenazi M; Nayak S; Bourdon M; Safar J; Ueberheide B; Wisniewski T
Brain; 2020 Sep; 143(9):2803-2817. PubMed ID: 32812023
[TBL] [Abstract][Full Text] [Related]
10. Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg.
Tremblay MA; Acker CM; Davies P
J Alzheimers Dis; 2010; 19(2):721-33. PubMed ID: 20110615
[TBL] [Abstract][Full Text] [Related]
11. The kinase domain of CK1δ can be phosphorylated by Chk1.
Böhm T; Meng Z; Haas P; Henne-Bruns D; Rachidi N; Knippschild U; Bischof J
Biosci Biotechnol Biochem; 2019 Sep; 83(9):1663-1675. PubMed ID: 31094292
[TBL] [Abstract][Full Text] [Related]
12. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
13. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
14. Tau-Induced Ca
Wei YP; Ye JW; Wang X; Zhu LP; Hu QH; Wang Q; Ke D; Tian Q; Wang JZ
Neurosci Bull; 2018 Apr; 34(2):261-269. PubMed ID: 28646348
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's Disease and Tau Self-Assembly: In the Search of the Missing Link.
González A; Singh SK; Churruca M; Maccioni RB
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457009
[TBL] [Abstract][Full Text] [Related]
16. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
[TBL] [Abstract][Full Text] [Related]
17. Prediction of human tau 3D structure, and interplay between O-β-GlcNAc and phosphorylation modifications in Alzheimer's disease: C. elegans as a suitable model to study these interactions in vivo.
Ahmad W; Shabbiri K; Ahmad I
Biochem Biophys Res Commun; 2020 Jul; 528(3):466-472. PubMed ID: 32499112
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo.
Giamas G; Hirner H; Shoshiashvili L; Grothey A; Gessert S; Kühl M; Henne-Bruns D; Vorgias CE; Knippschild U
Biochem J; 2007 Sep; 406(3):389-98. PubMed ID: 17594292
[TBL] [Abstract][Full Text] [Related]
19. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
20. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
